Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Voltage-gated calcium channel-Protein Kinase A (VGCC-PKA) signaling pathway in glutamatergic terminals is a fundamental regulatory mechanism for excitatory neurotransmission in the central nervous system. This pathway involves the activation of Protein Kinase A (PKA) via the cAMP second messenger system, which subsequently phosphorylates presynaptic voltage-gated calcium channels, specifically the N-type (Cav2.2) and P/Q-type (Cav2.1) channels (UniProt O00555, Q00975). Phosphorylation increases the open-probability and conductance of these channels, leading to enhanced calcium influx during neuronal depolarization and a corresponding increase in the release of glutamate into the synaptic cleft (Journal of Neuroscience, 2004). This mechanism is a key driver of synaptic plasticity and long-term potentiation, but its dysregulation is heavily implicated in pathological states such as chronic neuropathic pain and epilepsy, where it contributes to neuronal hyper-excitability (Nature Reviews Drug Discovery, 2007). Therapeutic interventions often target this pathway to dampen excessive glutamatergic signaling; for example, gabapentinoids bind to the alpha2-delta subunit of VGCCs to reduce channel trafficking, while opioids activate Gi/o-coupled receptors to inhibit adenylyl cyclase, thereby reducing PKA activity and subsequent calcium-dependent glutamate release (StatPearls, 2023).
Modulation of presynaptic calcium influx through PKA-mediated phosphorylation of calcium channels to regulate the exocytosis of glutamate-containing vesicles.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel-Protein Kinase A signaling pathway (VGCC-PKA pathway).